PE majors eye Orbicular Pharma stake, valuation seen up to $1.5 bn
Mumbai, Sept. 15 -- Orbicular Pharmaceutical Technologies has attracted early interest from private equity firms including Warburg Pincus and CVC Capital Partners, as the specialty pharmaceutical firm explores a stake sale in a deal that will likely value the company at up to $1.5 billion, three pe…